Ipilimumab augments antitumor activity of bispecific antibody-armed T cells.

Yano, Hiroshi

Ipilimumab augments antitumor activity of bispecific antibody-armed T cells. [electronic resource] - Journal of translational medicine Jul 2014 - 191 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1479-5876

10.1186/1479-5876-12-191 doi


Antibodies, Bispecific--immunology
Antibodies, Monoclonal--immunology
CD3 Complex--immunology
CTLA-4 Antigen--immunology
Cell Line, Tumor
Humans
Ipilimumab
T-Lymphocytes--immunology